BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of the anticancer agent sulofenur in mice, rats, monkeys, and dogs. 1993

W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Department of Drug Metabolism, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285.

The absorption and pharmacokinetics of sulofenur [N-(indan-5-sulfonyl)-N'-(4-chlorophenyl)urea, LY186641] and its major metabolites were examined in mice, rats, monkeys, and dogs. The compound is a diarylsulfonylurea currently being evaluated as an oncolytic agent in phase I and II trials. In all species, sulofenur was well absorbed after an oral dose, but over a prolonged period, and sulofenur exhibited a fairly long half-life of elimination from plasma. These values ranged from 6 h in rats up to 30, 110, and 200 h in mice, monkeys, and dogs, respectively, at doses (240-1000 mg/m2) within the range of those used in clinical trials. Experiments describing the high degree of binding of sulofenur to plasma proteins (consistently > 99%) help to explain these relatively long half-lives. There is, however, a large difference between these plasma half-lives in the species studied. Sulofenur was previously found to be extensively metabolized to products that are excreted primarily into the urine. In this study, its major metabolites, which are found mainly in the urine, were also minor components of the drug-related material (< 10% of the sulofenur concentrations) in the plasma of rats treated with sulofenur. The absorption, binding characteristics, and elimination of these major metabolites after their administration to rats were also compared with sulofenur.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.
January 1992, Drug metabolism and disposition: the biological fate of chemicals,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
The pharmacokinetics of indecainide in mice, rats, dogs, and monkeys.
January 1984, Drug metabolism and disposition: the biological fate of chemicals,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeys.
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of flunoxaprofen in rats, dogs, and monkeys.
August 1988, Journal of pharmaceutical sciences,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys.
March 2000, Antimicrobial agents and chemotherapy,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
July 1983, Antimicrobial agents and chemotherapy,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of the inodilator XB513 in mice, rats, guinea pigs, rabbits, dogs, and monkeys.
December 1994, Biopharmaceutics & drug disposition,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys.
August 1982, Antimicrobial agents and chemotherapy,
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
A 40-week male fertility study of the anticancer agent sulofenur (LY186641) administered orally to rats.
January 1992, Reproductive toxicology (Elmsford, N.Y.),
W J Ehlhardt, and H R Sullivan, and P G Wood, and J M Woodland, and M Hamilton, and C Hamilton, and D Cornpropst, and G B Grindey, and J F Worzalla, and J R Bewley
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
January 1986, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!